Eduard Montanya

Head Research Group

Hospital Universitari de Bellvitge

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eduard Montanya is the Head Research Group at the Institut d'Investigacio Biomedica de Bellvitge in Spain. His research focuses on diabetes, with recent publications exploring topics such as β-cell identity loss, machine learning approaches for diabetes diagnosis, and the role of noncoding regulatory functions in insulinoma development. Additionally, he investigates the impact of various treatments on diabetes management and associated health conditions.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (9)

Juan-Carlos Perez-Cortes

Tenured Professor

Universitat Politècnica de València

SPAIN

View details

Alexandra Title

ETH Zürich

SWITZERLAND

View details

Noelia Tellez

Associate Professor in Immunology and Basic Sciences

Universitat de Vic - Universitat Central de Catalunya

SPAIN

View details

Carlos Castaño Perez

Institut d'Investigació Sanitària Pere Virgili

SPAIN

View details

Lorenzo Pasquali

Group Leader-Research Professor

Universitat Pompeu Fabra

SPAIN

View details

Ramon Bosch Príncep

Professor associat

Universidad Rovira i Virgili

SPAIN

View details

Florian Szymczak

Université libre de Bruxelles (ULB)

BELGIUM

View details

José Ramón Navarro-Cerdán

SPAIN

View details

Murad Chowdhury

University of Colorado Boulder

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eduard Montanya

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Loss of β‐cell identity in human islets treated with glibenclamide

A machine learning approach for type 2 diabetes diagnosis and prognosis using tailored heterogeneous feature subsets

SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

Implications of noncoding regulatory functions in the development of insulinomas

Interferons are key cytokines acting on pancreatic islets in type 1 diabetes

Cross‐sectional association between severe periodontitis and diabetes mellitus: A nation‐wide cohort study

Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies

Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis

NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension

Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme

Collaborators (9)

Juan-Carlos Perez-Cortes

Alexandra Title

Noelia Tellez

Carlos Castaño Perez

Lorenzo Pasquali

Ramon Bosch Príncep

Florian Szymczak

José Ramón Navarro-Cerdán

Murad Chowdhury

Make your next move.